C10H12N2O5 6H-Furo[2′,3′:4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrah ydro-3-hydroxy-2-(hydroxymethyl)- 7-methyl-, (2R,3 R,3aS,9aR)- (9CI, ACI)

KANAKA MANAKA

O=C1N=C2OC3C(O)C(OC3N2C=C1C)CO

NĀ ʻAʻO ʻIsomeric

O[C@H]1[C@]2([C@](N3C(O2)= NC(=O)C(C)=C3)(O[C@@H]1CO)[H])[ H]

InChI

InChI= 1S/C10H12N2O5/c1-4-2-12-9-7(6(14)5(3-13)16-9)17-10(12)11-8(4)15/h2,5- 7,9,13-14H,3H2,1H3/t5-,6-,7+,9-/m1/s1

InChI Ki

WLLOAUCNUMYOQI-JAGXHNFQSA-N

17 Nā inoa ʻē aʻe no kēia mea

(2R,3 R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-2-(hydroxymethyl)-7-methyl-6H-furo[2′,3′:4,5]oxazolo[3,2-a] pyrimidin-6-one (ACI);

6H-Furo[2′,3′:4,5]oxazolo[3,2-a] pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-7-methyl- (6CI, 7CI, 8CI); 6H-Furo

[2′,3′:4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-7-methyl-, [2R-(2α,3β,3aβ,9aβ)]- (ZCI);

11: PN: US20040014699 PAGE: 18 i koi ʻia DNA; 12: PN: US20040005565 PAGE: 17- 22 i koi ʻia DNA; 12: PN: US20040005570 PAGE: 18 i koi ʻia ʻo DNA; 12: PN: US20040006029 PAGE: 21 i koi ʻia DNA; 12: PN: US20040014051 PAGE: 21 i koi ʻia DNA; 1: PN: WO20050 06958 PAGE: 59 i koi ʻia DNA; 2,2′ -Anhydro(1- β -D-arabinofuranosyl)- 5-methyluracil; 3: PN: WO2005007825 PAGE: 59 i ʻōlelo ʻia he DNA; 84: PN: US20040005707 ʻAoʻao: 18 i koi ʻia DNA; 9: PN: US20040014048 ʻAoʻao: 19 i koi ʻia DNA; 9: PN: US20040014049 ʻAoʻao: 19

ʻōlelo ʻia ʻo DNA;O2,2′ -Anhydro-5-methyluridine; O2,2′ -Anhydro-5-methyluridine; TK 112690